JOHNSON & JOHNSON (JNJ) vs PEPSICO INC(PEP)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | JNJ | PEP |
|---|---|---|
| Sector | Health Care | Consumer Staples |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $94.19B | $93.92B |
| Revenue growth (YoY) | ▲ 6.0% | ▲ 2.3% |
| Net income | $26.80B | $8.29B |
| Gross margin | 67.9% | 54.1% |
| Diluted EPS | $11.03 | $6.00 |
| Insider net (6 mo) | −40.8K sh · 6 sells · 0 buys | −850.9K sh · 4 sells · 0 buys |
| Institutional owners | 47 | 48 |
| Institutional value held | $294.77B | $94.40B |
| Next earnings (est.) | Around Oct 13, 2026 | Around Oct 8, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products.
About PEPSICO INC (PEP)
PepsiCo, Inc., incorporated in Delaware in 1919 and reincorporated in North Carolina in 1986, is a leading global beverage and convenient food company operating through its consolidated subsidiaries under a portfolio of well-known brands including Lay's, Dorit
Source: SEC EDGAR.